Botanix Pharmaceuticals Overview

  • Founded
  • 2015

Founded
  • Status
  • Public

  • Employees
  • 1

Employees
  • Stock Symbol
  • BOT

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.04

  • (As of Friday Closing)

Botanix Pharmaceuticals General Information

Description

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Contact Information

Formerly Known As
Botanix Pharma
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • PO Box 1407
  • Subiaco
  • Perth, Western Australia 6904
  • Australia
+61 (08) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Botanix Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.04 - $0.07 $47.4M 1.18B 948K

Botanix Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020
EV 38,870 33,230 42,492 9,421
EBITDA (9,440) (2,451) (11,225)
Net Income (9,544) (2,486) (11,207)
Total Assets 9,656 16,492 17,392
Total Debt 84 195 289
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Botanix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Botanix Pharmaceuticals‘s full profile, request access.

Request a free trial

Botanix Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development
Biotechnology
Perth, Australia
1 As of 2008
000.00
000000000 000.00

000000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000 000000000
Melbourne, Australia
00 As of 0000
00.00 0000-00-00
000000&0

000000

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
0000000000000
Lexington, MA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Botanix Pharmaceuticals Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clinuvel Pharmaceuticals Corporation Melbourne, Australia 00 000000&0
0000000 0000000000 Formerly VC-backed Lexington, MA 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Westlake Village, CA 000 00000 000000000 00000
000000000 00000000 Formerly VC-backed Tarrytown, NY 00000 00000 00000000000 00000
0000000 Formerly VC-backed San Diego, CA 0 000.00 00000000 000.00
You’re viewing 5 of 29 competitors. Get the full list »

Botanix Pharmaceuticals Patents

Botanix Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021904095-A0 Cbd cannabinoids and cbd cannabinoid analogues Pending 16-Dec-2021
AU-2021901322-A0 Cbd cannabinoids and cbd cannabinoid analogues Pending 04-May-2021
AU-2020904816-A0 Cbd cannabinoids and cbd cannabinoid analogues Pending 23-Dec-2020
AU-2020903438-A0 Antibacterial treatment using a cannabinoid and an active agent Pending 24-Sep-2020
AU-2019904935-A0 Cannabinoids and cannabinoid analogues with antimicrobial activity Inactive 24-Dec-2019
To view Botanix Pharmaceuticals’s complete patent history, request access »

Botanix Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Howie McKibbon Chief Operating Officer
Bill Bosch Executive Director & Chief Scientific Officer
Vince Ippolito President & Executive Chairman
Patricia Walker Ph.D Chief Medical Adviser
You’re viewing 4 of 7 executive team members. Get the full list »

Botanix Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Botanix Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Botanix Pharmaceuticals‘s full profile, request access.

Request a free trial

Botanix Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 04-May-2022 000000000 00.000 Buildings and Property 00000 000
Bone Medical 27-Jun-2016 Merger/Acquisition Pharmaceuticals
To view Botanix Pharmaceuticals’s complete investments and acquisitions history, request access »